On January 21, the annual meeting of customer appreciation and new product launch of Wanbangde Pharmaceutical Group was held in Yaoda International Hotel, Wenling City. This conference is rich in content, closely follows the development trend of the pharmaceutical industry, and focuses on the research of innovative drugs with independent intellectual property rights. Experts from China Pharmaceutical Enterprise Management Association, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhejiang University, Peking University Third Hospital and other units, as well as hundreds of industry insiders, partners and customers in the pharmaceutical industry gathered together to witness the new Product launch event.

The meeting began with a welcome speech by Chairman Zhao Shouming. He elaborated on the achievements of Wanbangde Pharmaceutical Group in new product research and development, brand building, capital expansion, and formulation of industry standards in 2017, and described the grand blueprint of Wanbangde Pharmaceutical Group. Partners, contribute to the leap-forward development of the pharmaceutical industry, and jointly undertake the mission of the revitalization of my country's traditional Chinese medicine industry.

Yu Mingde, Honorary President of China Pharmaceutical Enterprise Management Association, pointed out in a report entitled "Pharmaceutical Industry Situation and New Policy Learning", "In the past two decades, a series of policies that have been paid attention to, industry calls, and expert consensus have made major breakthroughs. , support innovation, promote transformation and upgrading, and inject lasting power into the development of the industry, which will greatly benefit the development of the industry." This opened the prelude to the conference. Subsequently, Tang Xican, academician of the Chinese Academy of Engineering, Zhang Haiyan, researcher of Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Fan Xiaohui, Dean of School of Pharmacy, Zhejiang University, Zhou Wei, Pediatric Expert of Peking University Third Hospital, Zhang Jian, Director of Translational Medicine Research Office of Jiangsu Academy of Traditional Chinese Medicine, Capital Experts such as Dr. Li Bo from the Medical University have successively discussed "Research Progress and Prospect of Alzheimer's Disease Drug Huperzine A", "Research Report on Secondary Development of Ginkgo Leaf Dropping Pills", and "Clinical Application of Ambroxol Solution for Inhalation" "Introduction to Clinical Application of Phloroglucinol Injection", "Introduction to Clinical Application of Huperzine A Injection", "Analysis of Clinical Localization of Gynostemma Gynostemma Glycosides Granules" and other topics were discussed, and the atmosphere was warm.

At the end of the meeting, the leadership of Wanbonde Pharmaceutical Group held a product seminar with partners and distributors across the country. Representatives of partners and distributors spoke enthusiastically, and put forward valuable opinions and suggestions on product academic support, market expansion methods, brand differentiation analysis of the same series of products, and product public welfare funds. Zhao Shouming, chairman of the group, listened carefully to the speeches of the participants, and pointed out that the development of the company is inseparable from the support of all partners and distributors. It will go all out to do a good job in the academic promotion of new products and the development of key products, comprehensively enhance the company's brand influence, and promote the product's market share in the country. In addition, he also stated that he will integrate the advantageous resources of all parties in order to achieve win-win cooperation with dealers.

Afterwards, Wanbangde Pharmaceutical Group held a thank you dinner, and more than 300 people gathered together. The lucky draw session of the dinner brought the atmosphere to the climax. The company provided dealers with generous prizes such as iPhone 10, ipad, wristband, etc. The meeting was also a complete success with laughter and laughter.

Chairman Zhao Shouming delivered a welcome speech

Chairman Zhao Shouming delivered a welcome speech

chairman Zhao S is on call delivered A welcome speech

New product discussion

Yu Mingde, Honorary President of China Pharmaceutical Enterprise Management Association, made a report

Zhang Haiyan from Shanghai Institute of Materia Medica, Chinese Academy of Sciences made a report

Chairman Zhao Shouming and Vice Chairman Zhuang Hui present awards to partners